Evidence map›Paper›PMID 33036497›Full record

ArticleMolecules (Basel, Switzerland)2020

Inhibition of

Gamal Enan, Abdul-Raouf Al-Mohammadi, Samir Mahgoub, Seham Abdel-Shafi, Eman Askar, Mohamed F Ghaly, Mohamed A Taha, Nashwa El-Gazzar

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 64 citations in OpenAlex.

  1. Prevention and Treatment ofPathogens (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Antimicrobial and cytotoxic activities of natural (Z)-13-docosenamide derived fromFrontiers in cellular and infection microbiology · 2025
    Article
  10. Evaluation ofCurrent drug delivery · 2025
    Article
  11. Article
  12. Article
  13. Antifungal and antibiofilm effects of probioticFrontiers in cellular and infection microbiology · 2024
    Article
  14. The Antiproliferative Activity ofMolecules (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Silver-Protein Nanocomposites as Antimicrobial Agents.Nanomaterials (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Gamal EnanDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.ORCID 0000-0001-7794-784X
Abdul-Raouf Al-MohammadiDepartment of Sciences, King Khalid Military Academy, Riyadh 11495, P.O. Box 22140, Saudi Arabia.
Samir MahgoubDepartment of Agricultural Microbiology, Faculty of Agriculture, Zagazig University, Zagazig 44511, Egypt.ORCID 0000-0003-4801-5757
Seham Abdel-ShafiDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.ORCID 0000-0002-8311-7946
Eman AskarDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
Mohamed F GhalyDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
Mohamed A TahaDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
Nashwa El-GazzarDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.ORCID 0000-0001-8229-9461
Zagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial outbreaks caused by

Indexed as

Anti-Bacterial AgentsMicrobial Sensitivity TestsMoringa oleiferaRNA, Ribosomal, 16SStaphylococcus aureusVirulence FactorsAnti-Bacterial AgentsRNA, Ribosomal, 16SVirulence FactorsGC-MS analysismoringaMSEStaphylococcus aureusvirulence factors

Identifiers

PMID33036497
PMCPMC7582841
OpenAlexW3092157930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.